Search

Showing "11155" results for ""

IAS: Incidence of some cancers increasing significantly in HIV-positive individuals

South Africa reports slight decline in HIV prevalence among pregnant women

IAS: Poor adherence and virological outcomes in children receiving HIV care in rural Uganda

IAS: HPV diversity suggests value of HIV-positive gay men receiving Gardasil

MMR revaccination safe and effective in children taking successful anti-HIV treatment

Over 50s do just as well on HIV treatment, but more likely to be diagnosed late and to change treatment sooner

IAS: Boosted atazanavir shows edge over unboosted in treatment-naive after 96 weeks

Were host factors or superinfection the key to case of rapid HIV progression?

Use CD4 cell count, not CD4 cell percentage to guide treatment decisions in all patients with HIV, even those with cirrhosis

IAS: Maraviroc produces best results when combined with another active drug

HPV vaccination doesn't help to clear the virus in women already infected

First fixed dose combination for children approved for PEPFAR use

Abbott warns on risk of overdose with Kaletra liquid

Towards a comprehensive package of preventive and palliative care

Viral load during primary infection influences viral load for years after

Patients with renal impairment often receive wrong NRTI dose, particular risk with combination pills

HIV/HBV coinfected patients should not take entecavir unless on anti-HIV treatment due to resistance risk

Frequency and seriousness of lactic acidosis mean that d4T should not be used in first-line therapy, say Ugandan researchers

Receive the latest HIV research and conference news

Showing "11155" results for ""

IAS: Incidence of some cancers increasing significantly in HIV-positive individuals

South Africa reports slight decline in HIV prevalence among pregnant women

IAS: Poor adherence and virological outcomes in children receiving HIV care in rural Uganda

IAS: HPV diversity suggests value of HIV-positive gay men receiving Gardasil

MMR revaccination safe and effective in children taking successful anti-HIV treatment

Over 50s do just as well on HIV treatment, but more likely to be diagnosed late and to change treatment sooner

IAS: Boosted atazanavir shows edge over unboosted in treatment-naive after 96 weeks

Were host factors or superinfection the key to case of rapid HIV progression?

Use CD4 cell count, not CD4 cell percentage to guide treatment decisions in all patients with HIV, even those with cirrhosis

IAS: Maraviroc produces best results when combined with another active drug

HPV vaccination doesn't help to clear the virus in women already infected

First fixed dose combination for children approved for PEPFAR use

Abbott warns on risk of overdose with Kaletra liquid

Towards a comprehensive package of preventive and palliative care

Viral load during primary infection influences viral load for years after

Patients with renal impairment often receive wrong NRTI dose, particular risk with combination pills

HIV/HBV coinfected patients should not take entecavir unless on anti-HIV treatment due to resistance risk

Frequency and seriousness of lactic acidosis mean that d4T should not be used in first-line therapy, say Ugandan researchers

Receive the latest HIV research and conference news